TSXV:BTI.H - Post by User
Post by
Boomskidon Jun 08, 2023 11:51pm
201 Views
Post# 35487830
Protalix
ProtalixIf Protalix is about to make an announcement that they have started or are going to start a Fabry/BBB program, then it is likely that this is known by Bioasis, and that they may have known it for some time. If this type of announcement comes, then there may very well be a developmental milestone payment to Bioasis triggered.
Further, if the development of an xB3/Fabry drug (xB3-Elfabrio) was dependent on FDA approval, then Bioasis would have known that for a long time, including during the time that the Midatech deal was being secretly set up.
And yet, if they did know this stuff, Bioasis went ahead with that awful Midatech deal with a timeliness that prevented Bioasis shareholders from knowing that this Fabry thing could happen.
The fact that we are now into June without the loss of xB3 to Lind may mean that Bioasis has received, or is about to receive, a milestone payment from Chiesi. (FDA approval of Elfabrio triggered a $20 million milestone payment by Chiesi to Protalix.)
It won't surprise me if Rathjen "saves" Bioasis with such an eventuality.
The June 27 Protalix event is a day or two before we would expect to see the Bioasis annual report. Rathjen likes timing these things in ways that suit her disclosure practices.
These things could be good but they still stink.
jd